Form 4: Annexon Director Jung Choi Granted 55,000 Stock Options

Annexon, Inc. Director Jung Choi was granted 55,000 stock options with an exercise price of $2.55, vesting over the next year or by the next annual meeting.

Summary

• Director Jung Choi of Annexon, Inc. (ANNX) was granted 55,000 stock options.
• The options have an exercise price of $2.55 per share.
• The options expire on June 5, 2035.
• The underlying shares will vest 100% on the earlier of June 5, 2026, or the next Annual Meeting following June 5, 2025, contingent on continuous service as a director.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive event as it aligns the director's interests with those of the shareholders, incentivizing long-term value creation. It is a routine compensation mechanism and does not indicate any negative operational or financial issues.

Positives

• The grant of 55,000 stock options to Director Jung Choi aligns management incentives with shareholder interests, promoting long-term value creation.

Future Outlook

The vesting schedule for the granted options, contingent on continuous service, suggests a future commitment of the director to the company's performance and long-term strategic goals.

Industry Context

The grant of stock options to a director is a common practice in the biotechnology and pharmaceutical industry, aligning executive and board member incentives with long-term company performance and shareholder value creation.

Comparison to Industry Standards

• The grant of stock options as part of director compensation is a widely accepted practice across publicly traded companies, particularly in growth-oriented sectors like biotechnology, to incentivize long-term commitment and performance.

Related Party Transactions

• The grant of stock options to Director Jung Choi is a standard compensation arrangement between the company and a related party (director).

Stakeholder Impact

• Shareholders: The grant of stock options to a director aligns their interests with shareholders, potentially leading to better long-term performance and value creation.

Next Steps

• The 55,000 stock options will vest 100% on the earlier of June 5, 2026, or the next Annual Meeting following June 5, 2025, subject to the director's continuous service.
• Upon vesting, the director will have the right to exercise the options at $2.55 per share until June 5, 2035.

Key Dates

Keywords

Annexon, ANNX, Stock Options, Director Compensation, Insider Transaction, Equity Grant, Form 4, Jung Choi